77 results
Page 3 of 4
8-K
EX-99.2
jnz5dnkkyh
14 Oct 21
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
9:00am
8-K
EX-99.1
b0a 415l7
14 Oct 21
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
9:00am
424B5
fvqyz ups596tmib
14 Oct 21
Prospectus supplement for primary offering
8:31am
424B5
e64yj
13 Oct 21
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
5hm8x3a
7 Sep 21
NeuroOne® Medical Technologies Corporation Receives FDA 510(k) Clearance for its Evo® sEEG Electrode
4:28pm
8-K
EX-99.1
hywzvzc
13 Aug 21
NeuroOne Reports Third Quarter Fiscal 2021 Financial Results and Corporate Update
8:05am
S-3
iyetg
4 Jun 21
Shelf registration
5:19pm
8-K
EX-99.1
smffe
25 May 21
NeuroOne Announces Approval for Nasdaq Capital Market Listing;Trading Expected to Commence Tomorrow May 26th, 2021 Under the Symbol NMTC
5:20pm
8-K
EX-99.1
fuhsztm pzyj8cfyqom
31 Mar 21
NeuroOne Medical Technologies Corporation Announces Reverse Stock Split as Part of Uplisting Strategy to Major Exchange
9:13am
424B3
079su 6kw
9 Mar 21
Prospectus supplement
9:01am
8-K
EX-99.1
m8v3g
23 Feb 21
NeuroOne Medical Technologies Corporation Announces Successful Completion of First
8:12am
8-K
EX-99.2
rvvhaciwes ikw5
15 Jan 21
NeuroOne Medical Technologies Corporation Announces Private Placement
8:08am
8-K
EX-99.1
adaqw3
15 Jan 21
NeuroOne Medical Technologies Corporation Announces Private Placement
8:08am
8-K
EX-99.1
vzcq4 orbxti2u
7 Jan 21
NeuroOne Medical Technologies Corporation Appoints Ronald McClurg, Experienced Financial Industry Executive, as Chief Financial Officer
8:59am
8-K
EX-99.1
cjhsyfa
6 Oct 20
NeuroOne Medical Technologies Corporation Provides Commercialization Update for EVO Cortical Electrode
8:29am
424B3
3yyhpf4
8 Sep 20
Prospectus supplement
9:25am